Olympian Picabo Street Announces She Just Had the Essure® Permanent Birth Control Procedure
Authored by Dr. Jen Iacovelli on 1/27/2010
Authored by Jen Iacovelli
1/27/2010
Categories: Newest Treatments, Health News, MomDocs Online
Categories: Newest Treatments, Health News, MomDocs Online
Olympian Picabo Street and her husband John Reeser announced last week that their youngest son, Dax Meyer Street Reeser, born in August of 2009, will be their last child. After evaluating all their birth control options, including a vasectomy, the couple decided that the Essure procedure was the best solution for them. By choosing the Essure procedure, Street avoided the added risk and recovery time associated with a surgical tubal ligation.
“When I look at my family, I know we are a complete unit,” says Picabo Street. “With the upcoming 2010 Olympic Games and my work as a national correspondent for NBC’s Today Show, I have no room for downtime associated with surgery or an unplanned pregnancy.”
“I am publicly speaking out about my choice to have the Essure procedure because permanent birth control is a decision that most couples make at some point in their relationship. People need to be aware of their options when it comes to any medical procedure to ensure that they do not subject themselves to the risk and recovery time associated with outdated surgery techniques,” continued Picabo. “I was shocked to learn how few women know about Essure and I want to empower and encourage women to become their own health advocates.”
Essure is a gentle permanent birth control procedure for women that can be performed in the comfort of one of our offices in minutes. The procedure is often preferred by women because it is a simple procedure that does not require cutting into the body, being put under general anesthesia, scarring, burning, hormones or downtime for recovery. Since receiving FDA approval in 2002, the Essure procedure has become a trusted solution for hundreds of thousands of women and their physicians. The Essure procedure is 99.74 percent effective with zero pregnancies reported in clinical trials, making it the most effective permanent birth control available.
